First Eagle Investment Management’s MacroGenics MGNX Stock Holding History

First Eagle Investment Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-175,000	Closed	-$3.58M	–	332
2016 Q4	$3.58M	Sell	175,000 -46,800	-21%	-$1.18M	0.01%	180
2016 Q3	$6.63M	Hold	221,800	–	–	0.02%	177
2016 Q2	$5.99M	Sell	221,800 -64,000	-22%	-$1.44M	0.02%	190
2016 Q1	$5.36M	Sell	285,800 -4,200	-1%	-$80K	0.01%	177
2015 Q4	$8.98M	Sell	290,000 -113,181	-28%	-$3.44M	0.02%	164
2015 Q3	$8.64M	Buy	403,181 +10,000	+3%	+$314K	0.02%	160
2015 Q2	$14.9M	Hold	393,181	–	–	0.04%	154
2015 Q1	$12.3M	Buy	393,181 +53,896	+16%	+$1.83M	0.03%	158
2014 Q4	$11.9M	Buy	339,285 +5,000	+1%	+$125K	0.03%	157
2014 Q3	$6.99M	Hold	334,285	–	–	0.02%	178
2014 Q2	$7.26M	Buy	+334,285	New	+$7.03M	0.02%	182

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

First Eagle Investment Management's MGNX Position: Q1 2017 in Review

First Eagle Investment Management sold out of MacroGenics (MGNX) in Q1 2017, closing a stake of 175,000 shares — an estimated $3.58M sold.

First Eagle Investment Management first reported a position in MGNX in Q2 2014 and held it in 11 quarters. The position peaked at $14.9M in Q2 2015. 111 funds tracked by Wall St. Rank hold MGNX as of Q1 2017.

First Eagle Investment Management reported no remaining MacroGenics position as of Q1 2017 after selling out during the quarter.
First Eagle Investment Management sold 175,000 MacroGenics shares in Q1 2017, an estimated $3.58M.
First Eagle Investment Management first reported a position in MacroGenics in Q2 2014 and held it in 11 quarters.
First Eagle Investment Management's MacroGenics position peaked at $14.9M in Q2 2015.
111 funds tracked by Wall St. Rank held MacroGenics as of Q1 2017.

Based on First Eagle Investment Management's 13F filing for Q1 2017, filed 5 May 2017.